IHE vs. NOBL
Compare and contrast key facts about iShares U.S. Pharmaceuticals ETF (IHE) and ProShares S&P 500 Dividend Aristocrats ETF (NOBL).
IHE and NOBL are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. IHE is a passively managed fund by iShares that tracks the performance of the Dow Jones U.S. Select Pharmaceuticals Index. It was launched on May 5, 2006. NOBL is a passively managed fund by ProShares that tracks the performance of the S&P 500 Dividend Aristocrats Index. It was launched on Oct 9, 2013. Both IHE and NOBL are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: IHE or NOBL.
Correlation
The correlation between IHE and NOBL is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
IHE vs. NOBL - Performance Comparison
Key characteristics
IHE:
0.88
NOBL:
0.82
IHE:
1.31
NOBL:
1.18
IHE:
1.16
NOBL:
1.14
IHE:
1.13
NOBL:
1.16
IHE:
2.74
NOBL:
3.51
IHE:
3.91%
NOBL:
2.42%
IHE:
12.17%
NOBL:
10.36%
IHE:
-38.20%
NOBL:
-35.43%
IHE:
-9.53%
NOBL:
-7.32%
Returns By Period
In the year-to-date period, IHE achieves a 7.58% return, which is significantly higher than NOBL's 7.14% return. Over the past 10 years, IHE has underperformed NOBL with an annualized return of 3.94%, while NOBL has yielded a comparatively higher 9.39% annualized return.
IHE
7.58%
-1.52%
-0.62%
9.27%
5.83%
3.94%
NOBL
7.14%
-4.74%
4.29%
7.79%
8.08%
9.39%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
IHE vs. NOBL - Expense Ratio Comparison
IHE has a 0.42% expense ratio, which is higher than NOBL's 0.35% expense ratio.
Risk-Adjusted Performance
IHE vs. NOBL - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares U.S. Pharmaceuticals ETF (IHE) and ProShares S&P 500 Dividend Aristocrats ETF (NOBL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
IHE vs. NOBL - Dividend Comparison
IHE's dividend yield for the trailing twelve months is around 1.62%, less than NOBL's 2.10% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IHE iShares U.S. Pharmaceuticals ETF | 1.41% | 1.39% | 2.01% | 1.49% | 1.19% | 1.40% | 1.25% | 1.36% | 0.92% | 1.93% | 1.20% | 1.06% |
NOBL ProShares S&P 500 Dividend Aristocrats ETF | 1.45% | 2.09% | 1.94% | 1.89% | 2.14% | 1.89% | 2.37% | 1.74% | 2.13% | 2.02% | 1.60% | 0.30% |
Drawdowns
IHE vs. NOBL - Drawdown Comparison
The maximum IHE drawdown since its inception was -38.20%, which is greater than NOBL's maximum drawdown of -35.43%. Use the drawdown chart below to compare losses from any high point for IHE and NOBL. For additional features, visit the drawdowns tool.
Volatility
IHE vs. NOBL - Volatility Comparison
The current volatility for iShares U.S. Pharmaceuticals ETF (IHE) is 3.11%, while ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has a volatility of 3.36%. This indicates that IHE experiences smaller price fluctuations and is considered to be less risky than NOBL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.